The 2 analysts offering 12-month price forecasts for Brickell Biotech Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +1,519.70% increase from the last price of 0.31.
The current consensus among 2 polled investment analysts is to Buy stock in Brickell Biotech Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.08
Reporting Date Mar 23
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.